Company intelligence / Profile preview

Quantum Dot Corporation

Hayward, California, United States

Ownership: Private
Employees: ~75
Development stage: Other

Overview

Quantum Dot Corporation commercialized quantum dot nanocrystals for fluorescence-based biomedical assays, enabling multiplexed imaging, more sensitive diagnostics, and faster drug discovery. Their Qdot platform improved imaging of cells, tissues, and molecular targets, with specific applications in cancer and ocular surgery. Clinical grade quantum dots for cancer and ocular imaging were developed with NIH grants, enhancing lymph node imaging during oncological surgery.

Therapeutic areas: OncologyOphthalmologyOther
Modalities: Nanoparticle
Industry: Protein Biomarker Diagnostics

Partnerships

University of California/Berkeley Lab (licensing)National Institute of Standards and Technology (grant funding)

Beyond the preview

Go deeper on Quantum Dot Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quantum Dot Corporation.

Explore the full profile